InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
10
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-9.6%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Vaddi Krishna. Insider active across 1 company, notably Prelude Therapeutics Inc. Aggregated, 11 filings have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €754k. Activity tracked since 13 December 2021. The latest transaction was filed on 25 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Vaddi Krishna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
675,000 shares@ US$0.692546.8% of flowCommon StockSEC:0001562180-25-002778:0
Canonical exit: 23 Jun 2025 (T+90)
5,416 shares@ US$0.72940.4% of flowCommon StockSEC:0001562180-25-002697:0
Canonical exit: 18 Jun 2025 (T+90)
29,999 shares@ US$0.75442.3% of flowCommon StockSEC:0001562180-25-002541:0
Canonical exit: 12 Jun 2025 (T+90)
47,500 shares@ US$0.71043.3% of flowCommon StockSEC:0001562180-25-002392:0
Canonical exit: 10 Jun 2025 (T+90)
5,000 shares@ US$1.20870.6% of flowCommon StockSEC:0001562180-25-000031:0
Canonical exit: 31 Mar 2025 (T+90)
10,000 shares@ US$1.201.2% of flowCommon StockSEC:0001562180-25-000008:0
Canonical exit: 30 Mar 2025 (T+90)
100,000 shares@ US$0.93219.6% of flowCommon StockSEC:0001562180-24-008531:0
Canonical exit: 18 Mar 2025 (T+90)
1,000 shares@ US$5.01140.5% of flowCommon StockSEC:0001562180-23-004517:0
Canonical exit: 22 Aug 2023 (T+90)
11,856 shares@ US$5.636.7% of flowCommon StockSEC:0001562180-23-004474:0
Canonical exit: 21 Aug 2023 (T+90)
19,188 shares@ US$5.130610.0% of flowCommon StockSEC:0001562180-22-008404:0
Canonical exit: 20 Mar 2023 (T+90)
8,000 shares@ US$12.129410.2% of flowCommon StockSEC:0001209191-21-069547:0
11 of 11 declarations
About Vaddi Krishna
Vaddi Krishna is a declarant linked to Prelude Therapeutics Inc, where the listed role is CEO. He has 11 filings in total, and, across the sampled recent filings, buy amounts total EUR 753565 and sell amounts total EUR 0, with transactions ranging from 2021-12-14 to 2025-03-27.
